A citation-based method for searching scientific literature

Sotirios G Papageorgiou, Thomas P Thomopoulos, Ioannis Katagas, Anthi Bouchla, Vassiliki Pappa. Ther Adv Hematol 2021
Times Cited: 5







List of co-cited articles
7 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma.
Anupama Reddy, Jenny Zhang, Nicholas S Davis, Andrea B Moffitt, Cassandra L Love, Alexander Waldrop, Sirpa Leppa, Annika Pasanen, Leo Meriranta, Marja-Liisa Karjalainen-Lindsberg,[...]. Cell 2017
561
40

Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte.
Bertrand Coiffier, Catherine Thieblemont, Eric Van Den Neste, Gérard Lepeu, Isabelle Plantier, Sylvie Castaigne, Sophie Lefort, Gérald Marit, Margaret Macro, Catherine Sebban,[...]. Blood 2010
936
40

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling.
A A Alizadeh, M B Eisen, R E Davis, C Ma, I S Lossos, A Rosenwald, J C Boldrick, H Sabet, T Tran, X Yu,[...]. Nature 2000
40

Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma.
Roland Schmitz, George W Wright, Da Wei Huang, Calvin A Johnson, James D Phelan, James Q Wang, Sandrine Roulland, Monica Kasbekar, Ryan M Young, Arthur L Shaffer,[...]. N Engl J Med 2018
881
40

2016 US lymphoid malignancy statistics by World Health Organization subtypes.
Lauren R Teras, Carol E DeSantis, James R Cerhan, Lindsay M Morton, Ahmedin Jemal, Christopher R Flowers. CA Cancer J Clin 2016
560
40

CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study.
Shimin Hu, Zijun Y Xu-Monette, Aarthi Balasubramanyam, Ganiraju C Manyam, Carlo Visco, Alexander Tzankov, Wei-min Liu, Roberto N Miranda, Li Zhang, Santiago Montes-Moreno,[...]. Blood 2013
155
40




The nucleolus functions as a phase-separated protein quality control compartment.
F Frottin, F Schueder, S Tiwary, R Gupta, R Körner, T Schlichthaerle, J Cox, R Jungmann, F U Hartl, M S Hipp. Science 2019
203
20

Regulation of Fas-mediated immune homeostasis by an activation-induced protein, Cyclon.
Shella Saint Fleur, Akemi Hoshino, Kimie Kondo, Takeshi Egawa, Hodaka Fujii. Blood 2009
14
20

Proteomic characterization of Pseudomonas aeruginosa PAO1 inner membrane.
Maria G Casabona, Yves Vandenbrouck, Ina Attree, Yohann Couté. Proteomics 2013
57
20

Nucleophosmin mutations confer an independent favorable prognostic impact in 869 pediatric patients with acute myeloid leukemia.
Lu-Hong Xu, Jian-Pei Fang, Yao-Chung Liu, Adrianna I Jones, Li Chai. Blood Cancer J 2020
11
20

The Need for a Consensus Next-generation Sequencing Panel for Mature Lymphoid Malignancies.
Pierre Sujobert, Yannick Le Bris, Laurence de Leval, Audrey Gros, Jean Philippe Merlio, Cedric Pastoret, Sarah Huet, Clémentine Sarkozy, Frédéric Davi, Mary Callanan,[...]. Hemasphere 2018
17
20

KPT-330 inhibitor of CRM1 (XPO1)-mediated nuclear export has selective anti-leukaemic activity in preclinical models of T-cell acute lymphoblastic leukaemia and acute myeloid leukaemia.
Julia Etchin, Takaomi Sanda, Marc R Mansour, Alex Kentsis, Joan Montero, Bonnie T Le, Amanda L Christie, Dilara McCauley, Scott J Rodig, Michael Kauffman,[...]. Br J Haematol 2013
130
20

The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP.
Laurie H Sehn, Brian Berry, Mukesh Chhanabhai, Catherine Fitzgerald, Karamjit Gill, Paul Hoskins, Richard Klasa, Kerry J Savage, Tamara Shenkier, Judy Sutherland,[...]. Blood 2007
928
20

Mutant nucleophosmin and cooperating pathways drive leukemia initiation and progression in mice.
George S Vassiliou, Jonathan L Cooper, Roland Rad, Juan Li, Stephen Rice, Anthony Uren, Lena Rad, Peter Ellis, Rob Andrews, Ruby Banerjee,[...]. Nat Genet 2011
153
20

Nucleophosmin regulates the stability and transcriptional activity of p53.
Emanuela Colombo, Jean-Christophe Marine, Davide Danovi, Brunangelo Falini, Pier Giuseppe Pelicci. Nat Cell Biol 2002
413
20

The potential role of nucleophosmin (NPM1) in the development of cancer.
Fateme Karimi Dermani, Saeideh Gholamzadeh Khoei, Saeid Afshar, Razieh Amini. J Cell Physiol 2021
9
20

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.
Andreas Rosenwald, George Wright, Wing C Chan, Joseph M Connors, Elias Campo, Richard I Fisher, Randy D Gascoyne, H Konrad Muller-Hermelink, Erlend B Smeland, Jena M Giltnane,[...]. N Engl J Med 2002
20

Age-related clonal hematopoiesis associated with adverse outcomes.
Siddhartha Jaiswal, Pierre Fontanillas, Jason Flannick, Alisa Manning, Peter V Grauman, Brenton G Mar, R Coleman Lindsley, Craig H Mermel, Noel Burtt, Alejandro Chavez,[...]. N Engl J Med 2014
20

Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype.
Brunangelo Falini, Cristina Mecucci, Enrico Tiacci, Myriam Alcalay, Roberto Rosati, Laura Pasqualucci, Roberta La Starza, Daniela Diverio, Emanuela Colombo, Antonella Santucci,[...]. N Engl J Med 2005
20

A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications.
George W Wright, Da Wei Huang, James D Phelan, Zana A Coulibaly, Sandrine Roulland, Ryan M Young, James Q Wang, Roland Schmitz, Ryan D Morin, Jeffrey Tang,[...]. Cancer Cell 2020
270
20

Targeting levels or oligomerization of nucleophosmin 1 induces differentiation and loss of survival of human AML cells with mutant NPM1.
Ramesh Balusu, Warren Fiskus, Rekha Rao, Daniel G Chong, Srilatha Nalluri, Uma Mudunuru, Hongwei Ma, Lei Chen, Sreedhar Venkannagari, Kyungsoo Ha,[...]. Blood 2011
95
20

The IgG Fc receptor, FcgammaRIIB, is a target for deregulation by chromosomal translocation in malignant lymphoma.
M B Callanan, P Le Baccon, P Mossuz, S Duley, C Bastard, R Hamoudi, M J Dyer, G Klobeck, R Rimokh, J J Sotto,[...]. Proc Natl Acad Sci U S A 2000
65
20

Conformational stabilization as a strategy to prevent nucleophosmin mislocalization in leukemia.
María A Urbaneja, Lars Skjærven, Oscar Aubi, Jarl Underhaug, David J López, Igor Arregi, Marián Alonso-Mariño, Andoni Cuevas, José A Rodríguez, Aurora Martinez,[...]. Sci Rep 2017
8
20

Proline: an efficient and user-friendly software suite for large-scale proteomics.
David Bouyssié, Anne-Marie Hesse, Emmanuelle Mouton-Barbosa, Magali Rompais, Charlotte Macron, Christine Carapito, Anne Gonzalez de Peredo, Yohann Couté, Véronique Dupierris, Alexandre Burel,[...]. Bioinformatics 2020
68
20

Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML): association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance.
Roel G W Verhaak, Chantal S Goudswaard, Wim van Putten, Maarten A Bijl, Mathijs A Sanders, Wendy Hugens, André G Uitterlinden, Claudia A J Erpelinck, Ruud Delwel, Bob Löwenberg,[...]. Blood 2005
436
20

DAPAR & ProStaR: software to perform statistical analyses in quantitative discovery proteomics.
Samuel Wieczorek, Florence Combes, Cosmin Lazar, Quentin Giai Gianetto, Laurent Gatto, Alexia Dorffer, Anne-Marie Hesse, Yohann Couté, Myriam Ferro, Christophe Bruley,[...]. Bioinformatics 2017
119
20

Selective inhibition of nuclear export with selinexor in patients with non-Hodgkin lymphoma.
John Kuruvilla, Michael Savona, Rachid Baz, Paul Morten Mau-Sorensen, Nashat Gabrail, Ramiro Garzon, Richard Stone, Michael Wang, Lynn Savoie, Peter Martin,[...]. Blood 2017
94
20

Identification of novel, clonally stable, somatic mutations targeting transcription factors PAX5 and NKX2-3, the epigenetic regulator LRIF1, and BRAF in a case of atypical B-cell chronic lymphocytic leukemia harboring a t(14;18)(q32;q21).
Bénédicte Burlet, Selim Ramla, Cyril Fournier, Maria Jimena Abrey-Recalde, Camille Sauter, Marie-Lorraine Chrétien, Cédric Rossi, Yannis Duffourd, Sylviane Ragot, Céline Buriller,[...]. Cold Spring Harb Mol Case Stud 2021
1
100


Identification of a role for Saccharomyces cerevisiae Cgr1p in pre-rRNA processing and 60S ribosome subunit synthesis.
Terence I Moy, Douglas Boettner, Judith C Rhodes, Pamela A Silver, David S Askew. Microbiology (Reading) 2002
22
20

Cytoscape: a software environment for integrated models of biomolecular interaction networks.
Paul Shannon, Andrew Markiel, Owen Ozier, Nitin S Baliga, Jonathan T Wang, Daniel Ramage, Nada Amin, Benno Schwikowski, Trey Ideker. Genome Res 2003
20

GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses.
Zefang Tang, Chenwei Li, Boxi Kang, Ge Gao, Cheng Li, Zemin Zhang. Nucleic Acids Res 2017
20

Identification of a novel BET bromodomain inhibitor-sensitive, gene regulatory circuit that controls Rituximab response and tumour growth in aggressive lymphoid cancers.
Anouk Emadali, Sophie Rousseaux, Juliana Bruder-Costa, Claire Rome, Samuel Duley, Sieme Hamaidia, Patricia Betton, Alexandra Debernardi, Dominique Leroux, Benoit Bernay,[...]. EMBO Mol Med 2013
55
20

Extranucleolar CYCLON Staining Pattern Is Strongly Associated to Relapse/Refractory Disease in R-CHOP-treated DLBCL.
Antonin Bouroumeau, Lucile Bussot, Hervé Sartelet, Cyril Fournier, Patricia Betton-Fraisse, Edwige Col, Laurence David-Boudet, Anne McLeer, Christine Lefebvre, Tatiana Raskovalova,[...]. Hemasphere 2021
1
100

Next-Generation Sequencing in Diffuse Large B-Cell Lymphoma Highlights Molecular Divergence and Therapeutic Opportunities: a LYSA Study.
Sydney Dubois, Pierre-Julien Viailly, Sylvain Mareschal, Elodie Bohers, Philippe Bertrand, Philippe Ruminy, Catherine Maingonnat, Jean-Philippe Jais, Pauline Peyrouze, Martin Figeac,[...]. Clin Cancer Res 2016
141
20

FunRich: An open access standalone functional enrichment and interaction network analysis tool.
Mohashin Pathan, Shivakumar Keerthikumar, Ching-Seng Ang, Lahiru Gangoda, Camelia Y J Quek, Nicholas A Williamson, Dmitri Mouradov, Oliver M Sieber, Richard J Simpson, Agus Salim,[...]. Proteomics 2015
749
20

A phase 1 clinical trial of single-agent selinexor in acute myeloid leukemia.
Ramiro Garzon, Michael Savona, Rachid Baz, Michael Andreeff, Nashat Gabrail, Martin Gutierrez, Lynn Savoie, Paul Morten Mau-Sorensen, Nina Wagner-Johnston, Karen Yee,[...]. Blood 2017
83
20

Nucleophosmin, a multifunctional nucleolar organizer with a role in DNA repair.
David J López, José A Rodríguez, Sonia Bañuelos. Biochim Biophys Acta Proteins Proteom 2020
17
20

The 2016 revision of the World Health Organization classification of lymphoid neoplasms.
Steven H Swerdlow, Elias Campo, Stefano A Pileri, Nancy Lee Harris, Harald Stein, Reiner Siebert, Ranjana Advani, Michele Ghielmini, Gilles A Salles, Andrew D Zelenetz,[...]. Blood 2016
20

Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma.
S W Morris, M N Kirstein, M B Valentine, K G Dittmer, D N Shapiro, D L Saltman, A T Look. Science 1994
20

Nucleophosmin integrates within the nucleolus via multi-modal interactions with proteins displaying R-rich linear motifs and rRNA.
Diana M Mitrea, Jaclyn A Cika, Clifford S Guy, David Ban, Priya R Banerjee, Christopher B Stanley, Amanda Nourse, Ashok A Deniz, Richard W Kriwacki. Elife 2016
261
20

The proto-oncogene MYC is required for selection in the germinal center and cyclic reentry.
David Dominguez-Sola, Gabriel D Victora, Carol Y Ying, Ryan T Phan, Masumichi Saito, Michel C Nussenzweig, Riccardo Dalla-Favera. Nat Immunol 2012
271
20

Phase I Study of the Anti-CD22 Antibody-Drug Conjugate Pinatuzumab Vedotin with/without Rituximab in Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma.
Ranjana H Advani, Daniel Lebovic, Andy Chen, Mark Brunvand, Andre Goy, Julie E Chang, Ephraim Hochberg, Sreeni Yalamanchili, Robert Kahn, Dan Lu,[...]. Clin Cancer Res 2017
49
20

Pembrolizumab in relapsed or refractory Hodgkin lymphoma: 2-year follow-up of KEYNOTE-087.
Robert Chen, Pier Luigi Zinzani, Hun Ju Lee, Philippe Armand, Nathalie A Johnson, Pauline Brice, John Radford, Vincent Ribrag, Daniel Molin, Theodoros P Vassilakopoulos,[...]. Blood 2019
160
20

Polatuzumab vedotin in combination with immunochemotherapy in patients with previously untreated diffuse large B-cell lymphoma: an open-label, non-randomised, phase 1b-2 study.
Hervé Tilly, Franck Morschhauser, Nancy L Bartlett, Amitkumar Mehta, Gilles Salles, Corinne Haioun, Javier Munoz, Andy I Chen, Kathryn Kolibaba, Dan Lu,[...]. Lancet Oncol 2019
74
20

Pembrolizumab-induced Remission After Failure of Axicabtagene Ciloleucel: Case Report and Literature Review.
Maria Dimou, Aikaterini Bitsani, Wolfgang Bethge, Panayiotis Panayiotidis, Theodoros P Vassilakopoulos. In Vivo 2021
2
50

Efficacy of Brentuximab Vedotin in Relapsed or Refractory High-CD30-Expressing Non-Hodgkin Lymphomas: Results of a Multicenter, Open-Labeled Phase II Trial.
Seok Jin Kim, Dok Hyun Yoon, Jin Seok Kim, Hye Jin Kang, Hye Won Lee, Hyeon-Seok Eom, Jung Yong Hong, Junhun Cho, Young Hyeh Ko, Jooryung Huh,[...]. Cancer Res Treat 2020
13
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.